Trial Profile
Plasma Protein Binding and Population Pharmacokinetics and Pharmacodynamics of Total and Unbound Temocillin in Patients With Complicated Urinary Tract Infection or Pyelonephritis, Lower Respiratory Tract Infection, or Abdominal Infection.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2022
Price :
$35
*
At a glance
- Drugs Temocillin (Primary)
- Indications Bacterial infections; Intra-abdominal infections; Pyelonephritis; Respiratory tract infections; Urinary tract infections
- Focus Pharmacokinetics
- Acronyms TEMODELTA
- 24 May 2022 Planned End Date changed from 15 Oct 2020 to 1 Apr 2023.
- 24 May 2022 Planned primary completion date changed from 15 Jul 2020 to 1 Apr 2023.
- 24 May 2022 Status changed from not yet recruiting to recruiting.